ES2044862T3 - Nitrato-reductasa soluble, estabilizada, dependiente de nad(p)h, procedimiento para su preparacion y aplicacion. - Google Patents

Nitrato-reductasa soluble, estabilizada, dependiente de nad(p)h, procedimiento para su preparacion y aplicacion.

Info

Publication number
ES2044862T3
ES2044862T3 ES87106305T ES87106305T ES2044862T3 ES 2044862 T3 ES2044862 T3 ES 2044862T3 ES 87106305 T ES87106305 T ES 87106305T ES 87106305 T ES87106305 T ES 87106305T ES 2044862 T3 ES2044862 T3 ES 2044862T3
Authority
ES
Spain
Prior art keywords
soluble
nad
dependent
reductase
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87106305T
Other languages
English (en)
Inventor
Stephan Dr Rer Nat Fischer
Barbel Wurst
Hans-Otto Dr Rer Nat Beutler
Georg-Burkhard Dr Rer N Kresse
Herwig Dr Brunner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Application granted granted Critical
Publication of ES2044862T3 publication Critical patent/ES2044862T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0036—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y107/00—Oxidoreductases acting on other nitrogenous compounds as donors (1.7)
    • C12Y107/01—Oxidoreductases acting on other nitrogenous compounds as donors (1.7) with NAD+ or NADP+ as acceptor (1.7.1)
    • C12Y107/01002—Nitrate reductase [NAD(P)H] (1.7.1.2)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

UNA NUEVA NITRATORREDUCTASA SOLUBLE, ESTABILIZADA, DEPENDIENTE DEL NAD(P) H, DEL TIPO ASIMILATIVO, PRESENTA UN PESO MOLECULAR DE APROXIMADAMENTE 90000 D Y UNA ACTIVIDAD RESIDUAL, AL CABO DE 3 SEMANAS A 35 GRADOS CENTIGRADOS SUPERIOR AL 60%, Y PUEDE OBTENERSE PREPARANDO UNA SUSPENSION DEL MATERIAL DE PARTIDA TRITURADO, EN UN TAMPON DE TRIS-ACIDO TARTARICO, DE PH 7-8,5, AÑADIENDO A ESTA SUSPENSION UNA POLIETILENIMINA SOLUBLE Y EN UNA CANTIDAD TAL QUE, AL PRECIPITADO QUE SE PRODUCE PASE DE UN 10 A UN 20% DE LA ACTIVIDAD DE LA NITRATORREDUCTASA, SEPARANDO EL PRECIPITADO Y ELABORANDO EL LIQUIDO SOBRENADANTE, SEGUN METODOS DE FRACCIONAMIENTO BIOQUIMICO USUALES, EN EL TAMPON DISGREGANTE ANTERIOR, DIALIZANDO LA SOLUCION ENZIMATICA OBTENIDA Y LIOFILIZANDOLA EN UN TAMPON DE ION ANFOTERO. ES ADECUADA PARA LA DETERMINACION DE NITRATO.
ES87106305T 1986-05-02 1987-04-30 Nitrato-reductasa soluble, estabilizada, dependiente de nad(p)h, procedimiento para su preparacion y aplicacion. Expired - Lifetime ES2044862T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863614838 DE3614838A1 (de) 1986-05-02 1986-05-02 Stabilisierte nad(p)h-abhaengige loesliche nitratreduktase verfahren zu ihrer herstellung und ihre verwendung

Publications (1)

Publication Number Publication Date
ES2044862T3 true ES2044862T3 (es) 1994-01-16

Family

ID=6299993

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87106305T Expired - Lifetime ES2044862T3 (es) 1986-05-02 1987-04-30 Nitrato-reductasa soluble, estabilizada, dependiente de nad(p)h, procedimiento para su preparacion y aplicacion.

Country Status (6)

Country Link
EP (1) EP0244771B1 (es)
JP (1) JPS62262992A (es)
AT (1) ATE84068T1 (es)
DE (2) DE3614838A1 (es)
ES (1) ES2044862T3 (es)
GR (1) GR3007473T3 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8903593D0 (en) * 1989-02-16 1989-04-05 Pafra Ltd Storage of materials
USRE38385E1 (en) * 1989-02-16 2004-01-13 Nektar Therapeutics Storage of materials
DE4004900A1 (de) * 1990-02-16 1991-08-22 Merck Patent Gmbh Nitratreduktase aus hefen, ihre herstellung und verwendung
EP0478827B1 (de) * 1990-10-04 1994-04-06 Kallies Import-Export Vertrieb Gmbh Stabilisiertes Thrombin, seine Herstellung und seine Verwendung als Thrombinzeitreagens
JP2562085B2 (ja) * 1991-02-21 1996-12-11 天野製薬株式会社 酵素の安定化方法
AU659645B2 (en) 1991-06-26 1995-05-25 Inhale Therapeutic Systems Storage of materials
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
US11282604B2 (en) 2019-10-03 2022-03-22 Rom Technologies, Inc. Method and system for use of telemedicine-enabled rehabilitative equipment for prediction of secondary disease
US11270795B2 (en) 2019-10-03 2022-03-08 Rom Technologies, Inc. Method and system for enabling physician-smart virtual conference rooms for use in a telehealth context
US11282599B2 (en) 2019-10-03 2022-03-22 Rom Technologies, Inc. System and method for use of telemedicine-enabled rehabilitative hardware and for encouragement of rehabilitative compliance through patient-based virtual shared sessions
US11139060B2 (en) 2019-10-03 2021-10-05 Rom Technologies, Inc. Method and system for creating an immersive enhanced reality-driven exercise experience for a user
US11515021B2 (en) 2019-10-03 2022-11-29 Rom Technologies, Inc. Method and system to analytically optimize telehealth practice-based billing processes and revenue while enabling regulatory compliance
US11282608B2 (en) 2019-10-03 2022-03-22 Rom Technologies, Inc. Method and system for using artificial intelligence and machine learning to provide recommendations to a healthcare provider in or near real-time during a telemedicine session

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1930059C3 (de) * 1969-06-13 1975-11-13 Boehringer Mannheim Gmbh Stabilisiertes Nicotinamid-adenindinucleotid oder bzw. und Nicotinamld-adenin-dinucleotidphosphat
NL7103489A (es) * 1970-03-18 1971-09-21
US4399218A (en) * 1980-02-05 1983-08-16 Boehringer Mannheim Gmbh Method and reagent for the determination of glycerin

Also Published As

Publication number Publication date
JPS62262992A (ja) 1987-11-16
DE3614838A1 (de) 1987-11-12
EP0244771B1 (de) 1992-12-30
JPH0475757B2 (es) 1992-12-01
ATE84068T1 (de) 1993-01-15
EP0244771A2 (de) 1987-11-11
EP0244771A3 (en) 1989-03-29
GR3007473T3 (es) 1993-07-30
DE3783265D1 (de) 1993-02-11

Similar Documents

Publication Publication Date Title
ES2044862T3 (es) Nitrato-reductasa soluble, estabilizada, dependiente de nad(p)h, procedimiento para su preparacion y aplicacion.
DE69535328D1 (de) In-vitro wachstum von langerhans'schen inseln und ihre verwendungen
SE9504077D0 (sv) Vätskeabsorberande artikel ansedd för engångsanvändning
ES8801930A1 (es) Procedimiento para la preparacion de dipeptidos de n,n'-dialquilguanidino
PH22075A (en) New complex compounds of piroxicam with cyclodextrin having antiinflammatory activity and pharmaceutical compositions containing them
DE59509100D1 (de) Gentherapeutische behandlung von tumoren mit einem endothelzellspezifischen, zellzyklusabhängigen wirkstoff
DK1115840T3 (da) Afstamningsspecifikke celler og progenitorceller
DE3266087D1 (en) Cysteine delivery system
JPS6485096A (en) Hybrid human protein c and biotechnological synthesis thereof
Bishop et al. Role of glutathione in transfer of amino acids from amino acyl-ribonucleic acid to ribosomes
ES8500218A1 (es) Un procedimiento para preparar peptidos sinteticos del tipo de las calcitoninas.
ATE63750T1 (de) Peptid, dessen herstellung und benutzung.
EP0830130A4 (en) TNF-ALPHA CONVERTING ENZYME
Lacombe et al. Proteolytic activation of adenylate cyclase from rat‐liver plasma membranes
Schürmann et al. Improved in vitro light activation and assay systems for two spinach chloroplast enzymes
EP0336779A3 (en) Polypeptides stabilized by covalent hydrogen bond replacements
EP0695184A4 (en) HIV PROTEASE INHIBITORS
ES2089177T3 (es) Nuevos peptidos inhibidores.
JPS5658488A (en) Refined "sake" with low alcohol content
Hersh Nomenclature for enkephalin degrading peptidases
ES2123669T3 (es) Derivados del plasminogeno que se activan con trombina.
EP1007647A4 (en) PRODUCTION OF THE INGAP PROTEIN WITH A HIGH EXPRESSION RATE
Callaway et al. Use of lectin affinity chromatography for the purification of collagenase from human polymorphonuclear leukocytes
Nicholson et al. A single chloroplast protein with latent activities of both N ADPH‐dependent glyceraldehyde‐3‐phosphate dehydrogenase and phosphoribulokinase
Sloane et al. Glutamine requirement for the inosinic acid transformylase reaction

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 244771

Country of ref document: ES